This program is derived from a lecture delivered at the 2023 Eastern Pulmonary Conference. The expert faculty, Drs. Reynold A. Panettieri Jr. and Anne E. O’Donnell, will highlight recent advances in the treatment and management of patients with non-tuberculous mycobacterial lung disease. The faculty will utilize a case-based approach to analyze current clinical trial data of amikacin-based inhalation therapeutics for the treatment of NTM-LD. Best practices for developing guideline-driven individualized treatment plans to improve outcomes and quality of life for patients with NTM-LD will be relayed in an interactive panel format.
Pulmonologists and other HCPs who care for patients with NTM-LD
Review NTM-LD pathophysiology associated patient risk factors/signs/symptoms, underlying conditions including bronchiectasis, and strategies for early and accurate diagnosis
Analyze clinical trial data of amikacin-based inhalation therapeutics for the treatment of NTM-LD
Develop guideline-driven individualized treatment plans coordinating anti-microbial therapy with respiratory therapy to improve outcomes for patients with NTM-LD
NTM-LD Update: Risk Factors, Accurate Diagnosis, and Comorbidities
Clinical Trial Analysis of Amikacin-Based Inhalation Therapeutics for the Treatment of NTM-LD
Challenging Patient Case Presentations – Guideline-Driven Individualized Treatment Plans to Improve Outcomes for Patients with NTM-LD
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Reynold A. Panettieri Jr., MD | Consultant/Advisor: AstraZeneca; Genentech, Inc.; Praesidia Biotherapeutics Inc.; RIFM; Teva Pharmaceutical Industries Ltd.
Research/Grant Support: ACTIV-1; Agomab Therapeutics; AstraZeneca; Janssen Pharmaceuticals; Medimmune; RIFM; Teva Pharmaceutical Industries Ltd.; Vault Health Speaker’s Bureau: AstraZeneca; Merck Corporation; Sanofi |
| Anne E. O’Donnell, MD | Consultant/Advisor: Boehringer Ingelheim International GmbH; Insmed; Paratek Pharmaceuticals
Research/Grant Support: AN2 Therapeutics; Boehringer Ingelheim International GmbH; Insmed; Paratek Pharmaceuticals; RedHill Biopharma Ltd. |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM.
Physcians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been supported by an independent educational grant from Insmed.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Insmed do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to claim credit, participants must complete the following:
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606